Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy-Reference-Cited by-同舟云学术

Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy

Published:2021-10-06 Issue:3 Volume:128 Page:536-546
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Garcia Sofia F.¹^ORCID,Gray Robert J.²³,Sparano Joseph A.⁴,Tevaarwerk Amye J.⁵^ORCID,Carlos Ruth C.⁶^ORCID,Yanez Betina¹^ORCID,Gareen Ilana F.⁷⁸,Whelan Timothy J.⁹,Sledge George W.¹⁰,Cella David¹,Wagner Lynne I.¹¹^ORCID

Affiliation:

1. Department of Medical Social Sciences Northwestern University, Feinberg School of Medicine Chicago Illinois

2. Dana‐Farber Cancer Institute Boston Massachusetts

3. ECOG‐ACRIN Biostatistics Center Boston Massachusetts

4. Montefiore Medical Center New York New York

5. University of Wisconsin Madison Wisconsin

6. University of Michigan Comprehensive Cancer Center Ann Arbor Michigan

7. Center for Statistical Sciences Brown University School of Public Health Providence Rhode Island

8. Department of Epidemiology Brown University School of Public Health Providence Rhode Island

9. Juravinski Cancer Center at Hamilton Health Sciences Hamilton Ontario Canada

10. Stanford Cancer Institute Palo Alto California

11. Wake Forest University Health Sciences Winston‐Salem North Carolina